VNQI vs XLV
Vanguard Global ex-US Real Estate ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.12% for VNQI.
- • VNQI pays a higher dividend yield (5.06%).
Side-by-side metrics
| Metric | VNQI | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.12% | 0.08% |
Dividend yield Trailing 12-month yield. | 5.06% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $3.53B | $49.10B |
YTD return | -3.75% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.92 | 0.41 |
P/E ratio | 10.97 | 30.63 |
Last price | $43.44 | $187.94 |
Inception | — | — |
Issuer | Vanguard | State Street |
VNQI top holdings
| GMG.AX | Goodman Group | 3.83% |
| 8802.T | Mitsubishi Estate Co Ltd | 2.75% |
| 8801.T | Mitsui Fudosan Co Ltd | 2.52% |
| 0016.HK | Sun Hung Kai Properties Ltd | 2.07% |
| EMAAR.AE | Emaar Properties PJSC | 1.96% |
| 8830.T | Sumitomo Realty & Development Co Ltd | 1.89% |
| 1925.T | Daiwa House Industry Co Ltd | 1.69% |
| SGRO.L | Segro PLC | 1.53% |
| VNA.DE | Vonovia SE | 1.40% |
| SCG.AX | Scentre Group | 1.26% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About VNQI
VNQI (Vanguard Global ex-US Real Estate ETF) is Non-US REITs and real estate companies globally. Managed by Vanguard, the fund carries $3.5B in assets under management, an expense ratio of 0.12%, a dividend yield of 5.06%. Its largest holding is Goodman Group (GMG.AX), which represents 3.8% of the portfolio. Real Estate is the fund's largest sector exposure at 98.7%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.